Shares of ANGLE plc (LON:AGL) fell 23.4% during mid-day trading on Friday . The stock traded as low as GBX 56 ($0.73) and last traded at GBX 56.70 ($0.74). 1,758,071 shares traded hands during mid-day trading, an increase of 1,555% from the average session volume of 106,228 shares. The stock had previously closed at GBX 74 ($0.97).
Separately, FinnCap restated a “corporate” rating on shares of ANGLE in a research note on Friday.
ILLEGAL ACTIVITY WARNING: This article was reported by Zolmax and is the property of of Zolmax. If you are reading this article on another domain, it was copied illegally and republished in violation of United States and international trademark and copyright law. The correct version of this article can be read at https://zolmax.com/investing/angle-agl-shares-down-23-4/2821623.html.
ANGLE Company Profile (LON:AGL)
ANGLE plc, a medical diagnostic company, provides cancer diagnostics and foetal health products. Its lead product is Parsortix cell separation system, which captures very rare circulating tumor cells in cancer patient blood. ANGLE plc was founded in 2004 and is based in Guildford, the United Kingdom.
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.